サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541627

人工授精市場レポート：タイプ別、供給源タイプ別、最終用途別、地域別、2024～2032年

Artificial Insemination Market Report by Type (Intrauterine, Intracervical, Intravaginal, Intratubal), Source Type (AIH-Husband, AID-Donor), End Use (Hospitals and Clinics, Fertility Centers, and Others), and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 145 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
人工授精市場レポート：タイプ別、供給源タイプ別、最終用途別、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の人工授精市場規模は2023年に21億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに42億米ドルに達し、2024～2032年の間に7.5％の成長率（CAGR）を示すと予測しています。不妊率の増加、ライフスタイルの急速な変化、病状の蔓延が市場を牽引する主要要因のひとつです。

人工授精は、医療処置によって精子を女性の生殖器官に直接入れる受精プロセスです。通常、新鮮精子または凍結精子を使用し、頸管内、子宮内、膣内などさまざまな方法で行われます。人工授精のコンポーネントには、精液の採取、精液の処理、精液の設置が含まれます。人工授精は、妊娠の確率を高め、性感染症（STI）のリスクを軽減し、男性不妊の場合にはドナーの精子を使用することができます。さらに、体外受精（IVF）と比較して、人工授精は低侵襲（MI）で費用対効果が高いです。現在、人工授精には主に同種と異種の2種類があります。同種人工授精では、男性パートナーの精子を使って女性パートナーの卵子を受精させるが、異種人工授精では、ドナー精子を使って女性パートナーの卵子を受精させる。

人工授精市場動向

不妊率の増加と生殖補助医療（ART）の必要性は、市場成長を後押しする主要因のひとつです。ライフスタイルの急速な変化と、多嚢胞性卵巣症候群（PCOS）や子宮内膜症などの病状の蔓延が人工授精の需要を急増させ、市場の成長をさらに加速させています。これはさらに、新興国での人工授精の受け入れと利用しやすさの向上にも支えられています。さらに、精子と卵子の選別、凍結保存、着床前遺伝子試験のための改良技術の開発など、さまざまな技術の進歩が市場成長を促進しています。このほか、ドナー精子やドナー卵子の入手可能性、同性婚やLGBTによる子育ての人気の高まり、医療インフラの改善なども市場成長を促進する要因として期待されています。さらに、有利な規制の存在、不妊症や人工授精に関する認識や教育キャンペーンの高まり、個別化・カスタマイズ型人工授精の需要の高まりなどが、市場成長を後押ししています。その他、人工授精サービスを提供するクリニックや医療施設の増加、人工授精処置に保険が適用されること、出産を遅らせてキャリア目標を追求する傾向が高まっていることなどが、市場成長を積極的に後押ししています。

本レポートで扱う主要質問

  • 人工授精市場の世界市場規模は？
  • 2024～2032年における世界の人工授精市場の予想成長率は？
  • 世界の人工授精市場を牽引する主要因は何か？
  • 世界の人工授精市場に対するCOVID-19の影響は？
  • 世界の人工授精市場のタイプ別内訳は？
  • 人工授精市場の用途別内訳は？
  • 人工授精市場の世界における主要地域は？
  • 世界の人工授精市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の人工授精市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 子宮内
  • 子宮頸管内
  • 膣内
  • 卵管内

第7章 市場内訳：供給源タイプ別

  • AIH
  • AID

第8章 市場内訳：最終用途別

  • 病院とクリニック
  • 不妊治療センター
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Conceivex Inc.
    • FUJIFILM Irvine Scientific Inc.（Fujifilm Holdings Corporation）
    • Genea Limited
    • Genus plc
    • Hamilton Thorne Inc.
    • Hi-Tech Solutions
    • Kitazato Corporation
    • Pride Angel
    • Rinovum Women's Health LLC
    • Rocket Medical plc
    • TenderNeeds Fertility LLC
    • Vitrolife AB
図表

List of Figures

  • Figure 1: Global: Artificial Insemination Market: Major Drivers and Challenges
  • Figure 2: Global: Artificial Insemination Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Artificial Insemination Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Artificial Insemination Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Artificial Insemination Market: Breakup by Source Type (in %), 2023
  • Figure 6: Global: Artificial Insemination Market: Breakup by End Use (in %), 2023
  • Figure 7: Global: Artificial Insemination Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Artificial Insemination (Intrauterine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Artificial Insemination (Intrauterine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Artificial Insemination (Intracervical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Artificial Insemination (Intracervical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Artificial Insemination (Intravaginal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Artificial Insemination (Intravaginal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Artificial Insemination (Intratubal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Artificial Insemination (Intratubal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Artificial Insemination (AIH-Husband) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Artificial Insemination (AIH-Husband) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Artificial Insemination (AID-Donor) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Artificial Insemination (AID-Donor) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Artificial Insemination (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Artificial Insemination (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Artificial Insemination (Fertility Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Artificial Insemination (Fertility Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Artificial Insemination (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Artificial Insemination (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia-Pacific: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia-Pacific: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Artificial Insemination Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Artificial Insemination Market: Breakup by Country (in %), 2023
  • Figure 74: Middle East and Africa: Artificial Insemination Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Global: Artificial Insemination Industry: SWOT Analysis
  • Figure 76: Global: Artificial Insemination Industry: Value Chain Analysis
  • Figure 77: Global: Artificial Insemination Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Artificial Insemination Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Artificial Insemination Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Artificial Insemination Market Forecast: Breakup by Source Type (in Million US$), 2024-2032
  • Table 4: Global: Artificial Insemination Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 5: Global: Artificial Insemination Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Artificial Insemination Market: Competitive Structure
  • Table 7: Global: Artificial Insemination Market: Key Players
目次
Product Code: SR112024A4023

The global artificial insemination market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.2 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032. Increasing infertility rates, rapid lifestyle changes, and escalating prevalence of medical conditions represent some of the key factors driving the market.

Artificial insemination is a process of fertilization that involves the placement of sperm directly into the female reproductive system through medical procedures. It typically involves the use of either fresh or frozen sperm and can be done in a variety of ways, including intracervical, intrauterine, or intravaginal methods. The components of artificial insemination include semen collection, semen processing, and semen placement. Artificial insemination offers increased chances of conception, reduced risk of sexually transmitted infections (STIs), and the ability to use donor sperm in cases of male infertility. Additionally, as compared to in vitro fertilization (IVF), artificial insemination is minimally invasive (MI) and cost-effective. Currently, there are two primary types of the procedure, including homologous and heterologous. Homologous insemination involves using the male partner's sperm to fertilize the female partner's egg, while heterologous insemination involves using donor sperm to fertilize the female partner's egg.

Artificial Insemination Market Trends:

The increasing infertility rates and the need for assisted reproductive technologies (ART) are some of the key factors boosting the market growth. The rapid lifestyle changes and escalating prevalence of medical conditions, such as polycystic ovary syndrome (PCOS) and endometriosis, have surged the demand for artificial insemination procedures, further accelerating the market growth. This is further supported by the growing acceptance and accessibility of artificial insemination in emerging economies. Moreover, various technological advancements, such as the development of improved techniques for sperm and egg selection, cryopreservation, and pre-implantation genetic testing, are propelling the market growth. Besides this, the availability of donor sperm and donor eggs, the rising popularity of same-sex marriage and LGBT parenting, and the improving healthcare infrastructure are factors expected to drive the market growth. Furthermore, the presence of favorable regulations, the growing awareness and education campaigns about infertility and artificial insemination, and the escalating demand for personalized and customized artificial insemination procedures are fueling the market growth. Other factors, such as the increasing number of clinics and healthcare facilities offering artificial insemination services, the availability of insurance coverage for the procedure, and the surging trend of delaying childbirth and pursuing career goals, are positively supporting the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial insemination market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, source type and end use.

Type Insights:

Intrauterine

Intracervical

Intravaginal

Intratubal

The report has provided a detailed breakup and analysis of the global artificial insemination market based on the type. This includes intrauterine, intracervical, intravaginal, and intratubal. According to the report, the intrauterine segment dominates the market.

Source Type Insights:

AIH-Husband

AID-Donor

The report has provided a detailed breakup and analysis of the global artificial insemination market based on the source type. This includes AIH-husband and AID-donor.

End Use Insights:

Hospitals and Clinics

Fertility Centers

Others

The report has provided a detailed breakup and analysis of the global artificial insemination market based on the end use. This includes hospitals and clinics, fertility centers, and others. According to the report, the fertility centers segment spearheads the market.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. As per the report, North America dominates the market. Some of the factors accelerating the North America artificial insemination market include the surging awareness regarding the advantages of artificial insemination, the rising consumer per capita expenditure, and burgeoning healthcare expenditure.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global artificial insemination market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Conceivex Inc., FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation), Genea Limited, Genus plc, Hamilton Thorne Inc., Hi-Tech Solutions, Kitazato Corporation, Pride Angel, Rinovum Women's Health LLC, Rocket Medical plc, TenderNeeds Fertility LLC, Vitrolife AB, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. How big is the global artificial insemination market?
  • 2. What is the expected growth rate of the global artificial insemination market during 2024-2032?
  • 3. What are the key factors driving the global artificial insemination market?
  • 4. What has been the impact of COVID-19 on the global artificial insemination market?
  • 5. What is the breakup of the global artificial insemination market based on the type?
  • 6. What is the breakup of the global artificial insemination market based on the end use?
  • 7. What are the key regions in the global artificial insemination market?
  • 8. Who are the key players/companies in the global artificial insemination market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Insemination Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Intrauterine
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intracervical
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Intravaginal
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Intratubal
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Source Type

  • 7.1 AIH-Husband
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 AID-Donor
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Fertility Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Conceivex Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Genea Limited
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Genus plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Hamilton Thorne Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Hi-Tech Solutions
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Kitazato Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Pride Angel
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Rinovum Women's Health LLC
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Rocket Medical plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 TenderNeeds Fertility LLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Vitrolife AB
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials